A recent drug safety scandal involving substandard vaccines in China has escalated after more than a week of public outrage, drawing rare public condemnation from China’s top officials.
Since July 17, Chinese pharmaceutical company Changsheng Bio-Technology and its subsidiary Changchun Changsheng came under fire for producing substandard vaccines and failing to recall their products in time. The former shipped out more than 250,000 doses of a faulty DTap vaccine to eastern China’s Shandong Province, while the latter forged data related to manufacturing its Vero-cell rabies vaccine.
